| Title : Quinoline-sulfonamides as a multi-targeting neurotherapeutic for cognitive decline: in vitro, in silico studies and ADME evaluation of monoamine oxidases and cholinesterases inhibitors - Jalil_2024_RSC.Adv_14_8905 |
| Author(s) : Jalil S , Hussain Z , Abid SMA , Hameed A , Iqbal J |
| Ref : RSC Adv , 14 :8905 , 2024 |
| Abstract : Jalil_2024_RSC.Adv_14_8905 |
| ESTHER : Jalil_2024_RSC.Adv_14_8905 |
| PubMedSearch : Jalil_2024_RSC.Adv_14_8905 |
| PubMedID: 38495980 |
| Title : Therapeutic potential of 1,3,4-oxadiazoles as potential lead compounds for the treatment of Alzheimer's disease - Naseem_2023_RSC.Adv_13_17526 |
| Author(s) : Naseem S , Temirak A , Imran A , Jalil S , Fatima S , Taslimi P , Iqbal J , Tasleem M , Tahir MN , Shafiq Z |
| Ref : RSC Adv , 13 :17526 , 2023 |
| Abstract : Naseem_2023_RSC.Adv_13_17526 |
| ESTHER : Naseem_2023_RSC.Adv_13_17526 |
| PubMedSearch : Naseem_2023_RSC.Adv_13_17526 |
| PubMedID: 37304812 |
| Title : 2-Oxoquinoline-based-thiosemicarbazones as multitargeting neurotherapeutics against Alzheimer's disease: In vitro and in silico studies of MAO and ChE inhibitors - Basri_2023_Arch.Pharm.(Weinheim)__e2300430 |
| Author(s) : Basri R , Fatima S , Jalil S , Imran A , Fatima N , Syed A , Bahkali AH , Iqbal J , Shafiq Z |
| Ref : Arch Pharm (Weinheim) , :e2300430 , 2023 |
| Abstract : Basri_2023_Arch.Pharm.(Weinheim)__e2300430 |
| ESTHER : Basri_2023_Arch.Pharm.(Weinheim)__e2300430 |
| PubMedSearch : Basri_2023_Arch.Pharm.(Weinheim)__e2300430 |
| PubMedID: 37718357 |
| Title : Synthesis and Evaluation of Novel S-alkyl Phthalimide- and S-benzyl-oxadiazole-quinoline Hybrids as Inhibitors of Monoamine Oxidase and Acetylcholinesterase - Khan_2022_Pharmaceuticals.(Basel)_16_ |
| Author(s) : Khan BA , Hamdani SS , Jalil S , Ejaz SA , Iqbal J , Shawky AM , Alqahtani AM , Gabr GA , Ibrahim MAA , Sidhom PA |
| Ref : Pharmaceuticals (Basel) , 16 : , 2022 |
| Abstract : Khan_2022_Pharmaceuticals.(Basel)_16_ |
| ESTHER : Khan_2022_Pharmaceuticals.(Basel)_16_ |
| PubMedSearch : Khan_2022_Pharmaceuticals.(Basel)_16_ |
| PubMedID: 36678507 |
| Title : Deep eutectic solvent mediated synthesis of 3,4-dihydropyrimidin-2(1H)-ones and evaluation of biological activities targeting neurodegenerative disorders - Saleem_2021_Bioorg.Chem_118_105457 |
| Author(s) : Saleem Khan M , Asif Nawaz M , Jalil S , Rashid F , Hameed A , Asari A , Mohamad H , Ur Rehman A , Iftikhar M , Iqbal J , Al-Rashida M |
| Ref : Bioorg Chem , 118 :105457 , 2021 |
| Abstract : Saleem_2021_Bioorg.Chem_118_105457 |
| ESTHER : Saleem_2021_Bioorg.Chem_118_105457 |
| PubMedSearch : Saleem_2021_Bioorg.Chem_118_105457 |
| PubMedID: 34798458 |
| Title : Withanolides, a new class of natural cholinesterase inhibitors with calcium antagonistic properties - Choudhary_2005_Biochem.Biophys.Res.Commun_334_276 |
| Author(s) : Choudhary MI , Nawaz SA , Ul-Haq Z , Lodhi MA , Ghayur MN , Jalil S , Riaz N , Yousuf S , Malik A , Gilani AH , ur-Rahman A |
| Ref : Biochemical & Biophysical Research Communications , 334 :276 , 2005 |
| Abstract : Choudhary_2005_Biochem.Biophys.Res.Commun_334_276 |
| ESTHER : Choudhary_2005_Biochem.Biophys.Res.Commun_334_276 |
| PubMedSearch : Choudhary_2005_Biochem.Biophys.Res.Commun_334_276 |
| PubMedID: 16108094 |
| Title : Juliflorine: a potent natural peripheral anionic-site-binding inhibitor of acetylcholinesterase with calcium-channel blocking potential, a leading candidate for Alzheimer's disease therapy - Choudhary_2005_Biochem.Biophys.Res.Commun_332_1171 |
| Author(s) : Choudhary MI , Nawaz SA , Zaheer ul H , Azim MK , Ghayur MN , Lodhi MA , Jalil S , Khalid A , Ahmed A , Rode BM , Atta ur R , Gilani AU , Ahmad VU |
| Ref : Biochemical & Biophysical Research Communications , 332 :1171 , 2005 |
| Abstract : Choudhary_2005_Biochem.Biophys.Res.Commun_332_1171 |
| ESTHER : Choudhary_2005_Biochem.Biophys.Res.Commun_332_1171 |
| PubMedSearch : Choudhary_2005_Biochem.Biophys.Res.Commun_332_1171 |
| PubMedID: 16021692 |